S&P 500   3,332.78 (-0.56%)
DOW   27,388.20 (-0.71%)
QQQ   276.05 (-0.41%)
AAPL   113.83 (-0.98%)
MSFT   208.27 (-0.56%)
FB   258.70 (+0.73%)
GOOGL   1,457.80 (-0.06%)
AMZN   3,161.78 (-0.39%)
TSLA   426.44 (+1.24%)
NVDA   526.65 (+1.01%)
BABA   276.98 (+0.35%)
CGC   14.57 (+2.53%)
MU   50.56 (+1.69%)
GE   6.08 (-1.94%)
AMD   81.43 (+2.45%)
T   28.18 (-0.70%)
F   6.56 (-1.94%)
ACB   4.93 (+3.14%)
GILD   62.12 (-1.16%)
NFLX   490.29 (-0.07%)
DIS   124.01 (-1.57%)
BA   163.00 (-1.85%)
BAC   23.60 (-2.03%)
S&P 500   3,332.78 (-0.56%)
DOW   27,388.20 (-0.71%)
QQQ   276.05 (-0.41%)
AAPL   113.83 (-0.98%)
MSFT   208.27 (-0.56%)
FB   258.70 (+0.73%)
GOOGL   1,457.80 (-0.06%)
AMZN   3,161.78 (-0.39%)
TSLA   426.44 (+1.24%)
NVDA   526.65 (+1.01%)
BABA   276.98 (+0.35%)
CGC   14.57 (+2.53%)
MU   50.56 (+1.69%)
GE   6.08 (-1.94%)
AMD   81.43 (+2.45%)
T   28.18 (-0.70%)
F   6.56 (-1.94%)
ACB   4.93 (+3.14%)
GILD   62.12 (-1.16%)
NFLX   490.29 (-0.07%)
DIS   124.01 (-1.57%)
BA   163.00 (-1.85%)
BAC   23.60 (-2.03%)
S&P 500   3,332.78 (-0.56%)
DOW   27,388.20 (-0.71%)
QQQ   276.05 (-0.41%)
AAPL   113.83 (-0.98%)
MSFT   208.27 (-0.56%)
FB   258.70 (+0.73%)
GOOGL   1,457.80 (-0.06%)
AMZN   3,161.78 (-0.39%)
TSLA   426.44 (+1.24%)
NVDA   526.65 (+1.01%)
BABA   276.98 (+0.35%)
CGC   14.57 (+2.53%)
MU   50.56 (+1.69%)
GE   6.08 (-1.94%)
AMD   81.43 (+2.45%)
T   28.18 (-0.70%)
F   6.56 (-1.94%)
ACB   4.93 (+3.14%)
GILD   62.12 (-1.16%)
NFLX   490.29 (-0.07%)
DIS   124.01 (-1.57%)
BA   163.00 (-1.85%)
BAC   23.60 (-2.03%)
S&P 500   3,332.78 (-0.56%)
DOW   27,388.20 (-0.71%)
QQQ   276.05 (-0.41%)
AAPL   113.83 (-0.98%)
MSFT   208.27 (-0.56%)
FB   258.70 (+0.73%)
GOOGL   1,457.80 (-0.06%)
AMZN   3,161.78 (-0.39%)
TSLA   426.44 (+1.24%)
NVDA   526.65 (+1.01%)
BABA   276.98 (+0.35%)
CGC   14.57 (+2.53%)
MU   50.56 (+1.69%)
GE   6.08 (-1.94%)
AMD   81.43 (+2.45%)
T   28.18 (-0.70%)
F   6.56 (-1.94%)
ACB   4.93 (+3.14%)
GILD   62.12 (-1.16%)
NFLX   490.29 (-0.07%)
DIS   124.01 (-1.57%)
BA   163.00 (-1.85%)
BAC   23.60 (-2.03%)
Log in
NYSEAMERICAN:AMPE

Ampio Pharmaceuticals Stock Forecast, Price & News

$0.91
-0.01 (-0.61 %)
(As of 09/29/2020 12:18 PM ET)
Add
Compare
Today's Range
$0.90
Now: $0.91
$0.92
50-Day Range N/A
52-Week Range
$0.26
Now: $0.91
$1.39
Volume16,766 shs
Average Volume2.69 million shs
Market Capitalization$161.43 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.
Read More
Ampio Pharmaceuticals logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.20 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Biotechnology
Sub-IndustryPharmaceuticals
SectorMedical
Current SymbolNYSEAMERICAN:AMPE
CUSIP03209T10
Phone+1-720-4376500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees22
Market Cap$161.43 million
Next Earnings Date11/5/2020 (Estimated)
OptionableOptionable
$0.91
-0.01 (-0.61 %)
(As of 09/29/2020 12:18 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AMPE News and Ratings via Email

Sign-up to receive the latest news and ratings for AMPE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Ampio Pharmaceuticals?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ampio Pharmaceuticals in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Ampio Pharmaceuticals
.

When is Ampio Pharmaceuticals' next earnings date?

Ampio Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Ampio Pharmaceuticals
.

How were Ampio Pharmaceuticals' earnings last quarter?

Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) issued its earnings results on Friday, July, 31st. The specialty pharmaceutical company reported ($0.02) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.04) by $0.02.
View Ampio Pharmaceuticals' earnings history
.

What price target have analysts set for AMPE?

1 brokerages have issued twelve-month price objectives for Ampio Pharmaceuticals' stock. Their forecasts range from $4.00 to $4.00. On average, they anticipate Ampio Pharmaceuticals' stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 337.4% from the stock's current price.
View analysts' price targets for Ampio Pharmaceuticals
.

Are investors shorting Ampio Pharmaceuticals?

Ampio Pharmaceuticals saw a increase in short interest in August. As of August 14th, there was short interest totaling 15,370,000 shares, an increase of 9.9% from the July 30th total of 13,980,000 shares. Based on an average daily trading volume, of 3,400,000 shares, the days-to-cover ratio is currently 4.5 days.
View Ampio Pharmaceuticals' Short Interest
.

Who are some of Ampio Pharmaceuticals' key competitors?

What other stocks do shareholders of Ampio Pharmaceuticals own?

Who are Ampio Pharmaceuticals' key executives?

Ampio Pharmaceuticals' management team includes the following people:
  • Mr. Michael E. Macaluso, Founder, Chairman & CEO (Age 67)
  • Mr. Thomas E. Chilcott III, CFO, Treasurer & Sec. (Age 51)
  • Ms. Holli Cherevka, Chief Operating Officer (Age 36)

What is Ampio Pharmaceuticals' stock symbol?

Ampio Pharmaceuticals trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "AMPE."

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Ampio Pharmaceuticals' stock price today?

One share of AMPE stock can currently be purchased for approximately $0.91.

How big of a company is Ampio Pharmaceuticals?

Ampio Pharmaceuticals has a market capitalization of $161.43 million. Ampio Pharmaceuticals employs 22 workers across the globe.

What is Ampio Pharmaceuticals' official website?

The official website for Ampio Pharmaceuticals is ampiopharma.com.

How can I contact Ampio Pharmaceuticals?

Ampio Pharmaceuticals' mailing address is 373 Inverness Pkwy Ste 200, ENGLEWOOD, CO 80112-5898, United States. The specialty pharmaceutical company can be reached via phone at +1-720-4376500.

This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.